Literature DB >> 34825836

Radioligand Therapy for Metastatic Prostate Cancer.

Brian J Burkett.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34825836      PMCID: PMC8637221          DOI: 10.1148/rycan.2021219026

Source DB:  PubMed          Journal:  Radiol Imaging Cancer        ISSN: 2638-616X


× No keyword cloud information.
  1 in total

1.  Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.

Authors:  Oliver Sartor; Johann de Bono; Kim N Chi; Karim Fizazi; Ken Herrmann; Kambiz Rahbar; Scott T Tagawa; Luke T Nordquist; Nitin Vaishampayan; Ghassan El-Haddad; Chandler H Park; Tomasz M Beer; Alison Armour; Wendy J Pérez-Contreras; Michelle DeSilvio; Euloge Kpamegan; Germo Gericke; Richard A Messmann; Michael J Morris; Bernd J Krause
Journal:  N Engl J Med       Date:  2021-06-23       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.